30
Participants
Start Date
August 31, 2021
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2027
Biospecimen Collection
Undergo tissue and blood sample collection
Bone Marrow Biopsy
Undergo bone marrow biopsy
Computed Tomography
Undergo PET/CT or CT
Cyclophosphamide
Given IV
Doxorubicin Hydrochloride
Given IV
Etoposide
Given IV
Lenalidomide
Given PO
Positron Emission Tomography
Undergo PET/CT
Prednisone
Given PO
Vincristine Sulfate
Given IV
RECRUITING
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
RECRUITING
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
SUSPENDED
NYP/Weill Cornell Medical Center, New York
RECRUITING
Memorial Sloan Kettering Westchester, Harrison
RECRUITING
NYU Langone Hospital - Long Island, Mineola
RECRUITING
Memorial Sloan Kettering Nassau, Uniondale
RECRUITING
Memorial Sloan Kettering Commack, Commack
RECRUITING
VCU Massey Comprehensive Cancer Center, Richmond
RECRUITING
Emory University Hospital Midtown, Atlanta
RECRUITING
Emory University Hospital/Winship Cancer Institute, Atlanta
RECRUITING
Ohio State University Comprehensive Cancer Center, Columbus
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
Siteman Cancer Center-South County, St Louis
RECRUITING
Siteman Cancer Center at West County Hospital, Creve Coeur
RECRUITING
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
RECRUITING
Memorial Sloan Kettering Basking Ridge, Basking Ridge
RECRUITING
Memorial Sloan Kettering Monmouth, Middletown
RECRUITING
Memorial Sloan Kettering Bergen, Montvale
National Cancer Institute (NCI)
NIH